These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35414604)

  • 1. Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people?
    Willicombe M; Scanlon M; Loud F; Lightstone L
    BMJ; 2022 Apr; 377():o966. PubMed ID: 35414604
    [No Abstract]   [Full Text] [Related]  

  • 2. Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients.
    Ameratunga R; Woon ST; Steele R; Lehnert K; Leung E; Edwards ESJ; Brooks AES
    Front Immunol; 2021; 12():798389. PubMed ID: 35116031
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration.
    Yi SG; Knight RJ; Graviss EA; Moore LW; Nguyen DT; Ghobrial RM; Gaber AO; Huang HJ
    Transplantation; 2021 Jul; 105(7):e72-e73. PubMed ID: 33741844
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N
    Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: A New mRNA Vaccine.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jun; 384(25):e109. PubMed ID: 34161714
    [No Abstract]   [Full Text] [Related]  

  • 7. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    Del Rio C; Malani PN; Omer SB
    JAMA; 2021 Sep; 326(11):1001-1002. PubMed ID: 34406361
    [No Abstract]   [Full Text] [Related]  

  • 9. Audio Interview: Protecting the Immunosuppressed against Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 May; 384(21):e88. PubMed ID: 34042395
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
    Parker EPK; Desai S; Marti M; Nohynek H; Kaslow DC; Kochhar S; O'Brien KL; Hombach J; Wilder-Smith A
    Lancet Glob Health; 2022 Mar; 10(3):e326-e328. PubMed ID: 35180408
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.
    Albach FN; Burmester GR; Biesen R
    Ann Rheum Dis; 2021 Oct; 80(10):1361-1362. PubMed ID: 34167947
    [No Abstract]   [Full Text] [Related]  

  • 12. CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
    Schulz E; Hodl I; Forstner P; Hatzl S; Sareban N; Moritz M; Fessler J; Dreo B; Uhl B; Url C; Grisold AJ; Khalil M; Kleinhappl B; Enzinger C; Stradner MH; Greinix HT; Schlenke P; Steinmetz I
    Front Immunol; 2021; 12():803742. PubMed ID: 34950155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
    Terpos E; Trougakos IP; Gavriatopoulou M; Papassotiriou I; Sklirou AD; Ntanasis-Stathopoulos I; Papanagnou ED; Fotiou D; Kastritis E; Dimopoulos MA
    Blood; 2021 Jul; 137(26):3674-3676. PubMed ID: 33861315
    [No Abstract]   [Full Text] [Related]  

  • 14. A French cohort for assessing COVID-19 vaccine responses in specific populations.
    Loubet P; Wittkop L; Tartour E; Parfait B; Barrou B; Blay JY; Hourmant M; Lachâtre M; Laplaud DA; Laville M; Laviolle B; Lelievre JD; Morel J; Nguyen S; Spano JP; Terrier B; Thiebaut A; Viallard JF; Vrtovsnik F; de Lamballerie X; Launay O
    Nat Med; 2021 Aug; 27(8):1319-1321. PubMed ID: 34253930
    [No Abstract]   [Full Text] [Related]  

  • 15. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
    Anderson M; Stec M; Rewane A; Landay A; Cloherty G; Moy J
    JAMA Netw Open; 2021 Aug; 4(8):e2119741. PubMed ID: 34357399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-COV-2 vaccination after stem cell transplantation for scleroderma.
    Rimar D; Slobodin G; Paz A; Henig I; Zuckerman T
    Ann Rheum Dis; 2021 Oct; 80(10):1354-1355. PubMed ID: 34049853
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 vaccination in immunocompromised patients.
    Sonani B; Aslam F; Goyal A; Patel J; Bansal P
    Clin Rheumatol; 2021 Feb; 40(2):797-798. PubMed ID: 33426632
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection.
    Pasikhova Y; Morrison AR; Katzman JH; Syed M
    Cancer Control; 2022; 29():10732748211070720. PubMed ID: 35001670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.